Rachel Ellingson Zimmer Biomet Holdings, Inc. (ZBH) insider trading activity

Rachel Ellingson is Chief Administrative Officer of ZIMMER BIOMET HOLDINGS, INC.. Currently has a direct ownership of 11,906 shares of ZBH, which is worth approximately $1.24 Million. The most recent transaction as insider was on Feb 20, 2025, when has been sold 491 shares (Common Stock) at a price of $103.46 per share, resulting in proceeds of $50,798. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.9K

73.91% 3M change

102.76% 12M change

Total Value Held $1.24 Million

Rachel Ellingson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 20 2025	SELL Payment of exercise price or tax liability	$50,798 $103.46 p/Share	491 Reduced 3.96%	11,906 Common Stock
Feb 20 2025	BUY Exercise of conversion of derivative security	-	1,566 Added 11.22%	12,397 Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$180,992 $101.0 p/Share	1,792 Reduced 14.2%	10,831 Common Stock
Feb 18 2025	BUY Exercise of conversion of derivative security	-	5,572 Added 30.62%	12,623 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$55,989 $125.82 p/Share	445 Reduced 6.1%	6,846 Common Stock
Mar 06 2024	BUY Exercise of conversion of derivative security	-	1,419 Added 16.29%	7,291 Common Stock
Feb 25 2024	SELL Payment of exercise price or tax liability	$75,734 $128.8 p/Share	588 Reduced 9.1%	5,872 Common Stock
Feb 25 2024	BUY Exercise of conversion of derivative security	-	1,762 Added 21.43%	6,460 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$45,027 $124.73 p/Share	361 Reduced 7.42%	4,503 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	1,046 Added 17.7%	4,864 Common Stock
May 01 2022	SELL Payment of exercise price or tax liability	$20,446 $122.43 p/Share	167 Reduced 4.41%	3,624 Common Stock
May 01 2022	BUY Exercise of conversion of derivative security	-	531 Added 12.29%	3,791 Common Stock
May 01 2021	SELL Payment of exercise price or tax liability	$28,718 $177.27 p/Share	162 Reduced 4.97%	3,098 Common Stock
May 01 2021	BUY Exercise of conversion of derivative security	-	515 Added 13.64%	3,260 Common Stock
Feb 26 2021	SELL Payment of exercise price or tax liability	$9,507 $163.92 p/Share	58 Reduced 2.07%	2,745 Common Stock
Feb 26 2021	BUY Exercise of conversion of derivative security	-	156 Added 5.27%	2,803 Common Stock

Also insider at

BLFS

BIOLIFE SOLUTIONS INC Healthcare

Director